Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
BackgroundTumors often progress to a more aggressive phenotype to resist drugs. Multiple dysregulated pathways are behind this tumor behavior which is known as cancer chemoresistance. Thus, there is an emerging need to discover pivotal signaling pathways involved in the resistance to chemotherapeuti...
Main Authors: | Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, Fatemeh Narimani, Carly E. Wallace, Anupam Bishayee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.834072/full |
Similar Items
-
Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-κB signaling cascade and inhibiting NLRP3 inflammasome activation
by: Shun Tang, et al.
Published: (2023-10-01) -
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
by: Sajad Fakhri, et al.
Published: (2022-03-01) -
Albiflorin attenuates sepsis-induced acute lung injury (ALI) via the TLR-4/NF-κB pathway
by: Qiongying Wei, et al.
Published: (2023-08-01) -
Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis
by: Asmaa I. Matouk, et al.
Published: (2022-11-01) -
TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy
by: Jinfeng Shen, et al.
Published: (2022-02-01)